AI and robotics, at the center of the VII edition of Empprende inHealth

The use of technology and digitization is growing in healthcare. So much so that half of the six award-winning projects this year at Emprende inHealth, Lilly’s and UnLimited Spain’s Health Social Impact Entrepreneurship Support Program uses artificial intelligence to diagnose eye diseases, neurological disorders and skin pathologies.

In addition, robotics, digital platforms such as solutions digital therapeutic and rapid tests stand out in the projects selected to treat musculoskeletal pathologies, traumatic and neurological pathologies of the wrist-hand-finger segment and sepsis in a personalized way.

Whatever the issues that these entrepreneurial projects seek to cover, the mission is common to all: provide solutions for the well-being and improvement of people’s quality of life. In short, to generate a positive impact on patients, family members and caregivers, healthcare professionals and the public health system.

In concrete terms, the projects selected in the VII edition of Emprende inSons of health:

• Medical DIVING: technology based on eye tracking and artificial intelligence for objective, automatic, fast and accurate screening and comprehensive examination of visual function, even in patients with barriers to cooperation, such as preverbal children or people with cognitive impairment . The device – portable and easy to use – makes it possible to reach anyone, even in hard-to-reach areas. This benefits health systems, which will be able to implement cost-effective screening, primary care, as it will reduce the high number of existing unnecessary referrals (40-50%) and eye care professionals.

• Inrobics rehabilitation: digital platform based on social robotics and artificial intelligence that offers rehabilitation sessions to people with limitations in their motor, cognitive and social abilities derived from neurological alterations. It has a humanoid robot and an RGB-D sensor that monitors and records patient movements. It is accessible from any mobile device or tablet with an internet connection. It is the first social robotics platform validated as a medical device.

• Legit health: first platform on the market with artificial intelligence algorithms and computer vision which is able to detect the presence, measure the severity and do an automated follow-up of more than 232 skin pathologies. It is aimed at health professionals to treat patients with chronic and malignant diseases in the dermatological field and aims to support their care and remote monitoring, as well as to facilitate communication with the doctor to improve the health outcomes.

• Adamo-robot: first collaborative robot that treats musculoskeletal pathologies by air pressure, without contact, in a non-invasive way and without pain for the patient. It provides thermographic data and contrasting, published scientific evidence. In addition, it allows to evaluate recovery times, shorten waiting lists and avoid occupational injuries. 100% of the people treated consider that the robot has helped them to improve.
• Loop-DX: Septiloop is the new emergency diagnostic device that identifies early bacteremia through the measurement of specific biomarkers of the immune response. Obtaining objective, quantifiable, physiological and clinically relevant information allows early diagnosis of septic infection. This way, doctors can treat the patient earlier, thereby reducing their mortality.

• Revise: the solution digital therapeutic for the rehabilitation of traumatic and neurological pathology of the wrist-hand-finger segment, which is one of the most frequent conditions, thanks to a tablet application that can be used both in the physiotherapy room and at home. This allows healthcare professionals to quickly prescribe treatment, monitor patients and monitor remotely. After trials with hundreds of participants, hospitals and clinics in Europe and Latin America are now using ReHand to treat their patients.

Accelerate healthcare solutions

The objective of the Emprende program inHealthcare consists of accelerating the solutions of emerging companies to make them available to patients, caregivers and healthcare professionals and innovating in the sector in different areas of specialization in Medicine.

Thus, each year, six startups receive mentoringadvice, training, networking and visibility of Lilly professionals who are experts in health, business and social impact. To date, this program has already supported 36 projects that have created 83 jobs and improved the quality of life for 268,680 people.

Nabil DaoudChairman of Lilly Spain, Portugal and Greece, Explain: “In its VII edition, Emprende inHealth consolidates itself as a program unique in its three aspects. And it is that it not only has a positive impact on society, but also on Lilly employees, who join corporate volunteering and in this innovative atmosphere are infected with the creativity, initiative and enthusiasm of startupsand entrepreneurs, who receive support from acceleration experts“.

For its part, lingerie manual, CEO and co-founder of UnLimited Spain, asserts that today, after the pandemic, “there is a need to continue providing entrepreneurs with the tools to turn their ideas into more innovative, socially positive and economically sustainable models. In this task, the team of great professionals of Lilly Spain plays a fundamental role“.

Finally, this program is also part of the Sustainable Development Goals of the 2030 Agenda set by the UN. It contributes to improving people’s health and well-being (SDG 3) and is aligned with SDG 8 on decent work and economic growth and SDG 17, which aims to build alliances to achieve Goals.